Dr. Choudhury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Da930
Boston, MA 02215Phone+1 617-632-6328Fax+1 617-632-2165
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2012- Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006
Certifications & Licensure
NH State Medical License 2024 - 2026
RI State Medical License 2022 - 2026
MA State Medical License 2009 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2019 May 29
- Abemaciclib With or Without Atezolizumab for mCRPC Start of enrollment: 2021 Aug 20
- Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC Start of enrollment: 2021 Jun 28
- Join now to see all
Publications & Presentations
PubMed
- 406 citationsWhole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancerJens G. Lohr, Viktor A. Adalsteinsson, Kristian Cibulskis, Atish D. Choudhury, Mara Rosenberg
Nature Biotechnology. 2014-05-01 - 110 citationsEZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied
Nature Cancer. 2021-03-22 - 513 citationsScalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumorsViktor A. Adalsteinsson, Gavin Ha, Samuel S. Freeman, Atish D. Choudhury, Daniel G. Stover
Nature Communications. 2017-11-06
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
- A Dose Finding Clinical Trial of Cabozantinib (XL184) Administered in Combination with Abiraterone Acetate in Metastatic Castration‐Resistant Prostate CancerChristopher Sweeney, Lauren C Harshman, Mark Pomerantz, Brandon Bernard, Atish D Choudhury, Philip W Kantoff, The Prostate
Press Mentions
Here Are Warning Signs That Men Age 15-35 Need to Know About Testicular CancerApril 7th, 2023- The Combination of Pembrolizumab and Radium-223 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Atish ChouduryFebruary 26th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
